Snibe Diagnostics has introduced an alternative chemiluminescence immunoassay (CLIA) system for in vitro diagnosis (IVD). Targeted for small and middle-size labs or hospitals, also a good choice as a backup instrument for big labs or hospitals, the compact design of MAGLUMI 800 significantly reduces analyzer size and weight, but still maintaining a throughput of 180 tests per hour. With more than enough test menu, different needs for immunologic diagnosis can also be adequately fulfilled.

MAGLUMI 800 uses two outstanding immunology technologies. The first one is labeling technology, which uses a non-enzyme small molecule called ABEI. The special molecular formula of ABEI greatly enhances stability in acid and alkaline solution. And the other one is separation technology, which is accomplished by nano-magnetic microbeads. With remarkable surface area, magnetic microbeads tremendously improve the sensitivity, accuracy, and precision of the reagents.

Compared to other models of Snibe Diagnostics or other manufacturers, MAGLUMI 800 is highlighted by its simple, smart, and humanized design, especially with the swivel pipetting arm for both samples and reagents. Moreover, cross-contamination is perfectly avoided by using a TEFLON-coated titanium needle, along with inner and external washing procedure. On the other hand, the fast-moving pipetting arm makes it a guarantee for enough testing speed.

Regarding the reagents, a spectacular test menu of over 138 assays is already presented, with more coming out every year. Ranging from thyroid, tumor markers and fertility to TORCH, hepatic fibrosis and infectious disease, Snibe diagnostics is attempting to provide the most comprehensive immunologic diagnostic solution. Besides, free internal control and built-in calibrators for reagent can greatly help to reduce the cost per test.

Combined with practicability and applicability, MAGLUMI 800 is particularly suitable for small and middle-size labs or hospitals, which have moderate testing amount and demand for various immunology assays.


A New Cancer Treatment

10 Unbelievable Innovation in Medicine

 

Digital version